Endocrine Insights focuses on six areas spanning endocrine and metabolic science, clinical research, and therapeutic development.
Hormonal regulation, endocrine disorders, and pathophysiology
Coverage includes the physiology and pathophysiology of endocrine glands and hormonal signaling, with attention to disorders of the thyroid, adrenal, pituitary, and gonadal axes, as well as emerging areas of endocrine science.
Metabolic disease, energy homeostasis, and cardiometabolic risk
Coverage includes the biology of metabolic disease, including type 2 diabetes, insulin resistance, dyslipidemia, and metabolic dysfunction-associated steatotic liver disease (MASLD), as well as the relationship between metabolic dysfunction and cardiovascular risk.
Obesity biology, pharmacotherapy, and clinical development
Coverage includes the pathophysiology of obesity, the pharmacology of approved and investigational anti-obesity agents, and the clinical development landscape for obesity therapeutics.
Drug mechanisms, clinical pharmacology, and treatment evidence
Coverage includes the mechanisms of action of endocrine and metabolic therapeutics, clinical pharmacology, and the interpretation of efficacy and safety evidence from clinical trials.
Trial design, endpoints, biomarkers, and evidence generation
Coverage includes the design and conduct of clinical trials in endocrine and metabolic disease, including endpoint selection, biomarker use, and the interpretation of clinical evidence.
Translational research, regulatory science, and development strategy
Coverage includes the translation of endocrine and metabolic science into drug development programs, regulatory considerations, and development strategy.